Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD

Clinical trial NCT01862926 · COMPLETED

Trial details

NCT number: NCT01862926
Sponsor: Royal Brompton & Harefield NHS Foundation Trust
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Interstitial Lung Disease Scleroderma Idiopathic Inflammatory Myositis Mixed Connective Tissue Disease

Start date: 2014-11-01
Primary completion: 2021-01-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.